Succinimidyl Carbonate Monomethoxypolyethylene Glycol E Coli L-Asparaginase
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Antineoplastic Agent -> Succinimidyl Carbonate Monomethoxypolyethylene Glycol E Coli L-Asparaginase
Succinimidyl Carbonate Monomethoxypolyethylene Glycol E Coli L-Asparaginase Definition
An intravenous formulation containing E.coli-derived L-asparaginase II conjugated with succinimidyl carbonate monomethoxypolyethylene glycol (SC-PEG), with potential antineoplastic activity. L-asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia, thereby depleting cells of asparagine; asparagine depletion blocks protein synthesis and tumor cell proliferation, especially in the G1 phase of the cell cycle and ultimately induces tumor cell death. Asparagine is critical to protein synthesis in acute lymphoblastic leukemia (ALL) cells which, unlike normal cells, cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. Pegylation decreases enzyme antigenicity and increases its half life. SC is used as a PEG linker to facilitate attachment to asparaginase and enhances the stability of the formulation.
Succinimidyl Carbonate Monomethoxypolyethylene Glycol E Coli L-Asparaginase Synonyms
SC-PEG E. Coli L-Asparaginase, EZN-2285, Oncaspar-IV, Succinimidyl Carbonate Monomethoxypolyethylene Glycol E. coli L-Asparaginase
Terms in Succinimidyl Carbonate Monomethoxypolyethylene Glycol E Coli L-Asparaginase category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.